<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320667">
  <stage>Registered</stage>
  <submitdate>30/09/2009</submitdate>
  <approvaldate>6/10/2009</approvaldate>
  <actrnumber>ACTRN12609000861257</actrnumber>
  <trial_identification>
    <studytitle>Comparison of Intraoperative Safety and Postoperative Lung Complications between two ventilation methods during lung resection surgery</studytitle>
    <scientifictitle>Comparison of Intraoperative Safety and Postoperative Lung Complications between Conventional and Protective One Lung Ventilation Strategies in Lung Resection Surgery</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>lung cancer</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Lung - Non small cell</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The protective ventilation strategy consists of fraction of inspired oxygen (FiO2) 0.5, tidal volume 6 ml//kg, end expiratory pressure 5 cmH2O, and pressure controlled ventilation./protective ventilation strategy applied during one lung ventilation (approximately 60 minutes)</interventions>
    <comparator>The conventional strategy consists of FiO2 1.0, tidal volume 10 ml/kg, zero end expiratory pressure, and volume controlled ventilation/conventional strategy applied during one lung ventilation (approximately 60 minutes)</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Lung complications within postoperative one week: arterial oxygen partial pressure (PaO2)/FiO2 &lt; 300 mmHg, and/or lung infiltration and atelectasis. Lung lesion is assessed by chest x-ray</outcome>
      <timepoint>Postoperative one week</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Intraoperative safety: oxygen saturation by pulse oxymeter, arterial carbon dioxide partial pressure, and airway pressure</outcome>
      <timepoint>During operation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Lung resction surgery: lobectomy, bilobectomy.
2. American society of anesthesiology physical status 1 or 2
3. Patients acceptance for the study</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. patients refusal 
2. cerebral, renal or liver diseases</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Enrolling: All patienst who meet the inclusion criteria during the study period 
Allocating:  Sealed envelope assignment</concealment>
    <sequence>Computer-generated random number table</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/05/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Korea, Republic Of</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Hyun Joo Ahn</primarysponsorname>
    <primarysponsoraddress>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, 50, Ilwon-Dong, Kangnam-Gu, Seoul, Korea, 135-710</primarysponsoraddress>
    <primarysponsorcountry>Korea, Republic Of</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Purpose: Comparison of postoperative lung complications between two ventilation methods in lung resection surgery.
Hypothesis: ventilation with low tidal volume and oxygen partial pressure, application of positive endexpiratory pressure, and pressrue controlled ventilation will reduce postoperative lung complications compared to conventional ventilation methods</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Institutional review board of Samsung medical center</ethicname>
      <ethicaddress>Samsung Medical Center, 
50, Ilwon-Dong, Kangnam-Gu, Seoul, Korea, 135-710</ethicaddress>
      <ethicapprovaldate>2/02/2009</ethicapprovaldate>
      <hrec>2009-01-043</hrec>
      <ethicsubmitdate>23/01/2009</ethicsubmitdate>
      <ethiccountry>Korea, Republic Of</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Hyun Joo Ahn</name>
      <address>Department of Anesthesiology and Pain Medicine, Samsung Medical
Center, 50, Ilwon-Dong, Kangnam-Gu, Seoul, Korea, 135-710</address>
      <phone>82-2-3410-0784</phone>
      <fax />
      <email>hyunjooahn@skku.edu</email>
      <country>Korea, Republic Of</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Hyun Joo Ahn</name>
      <address>Department of Anesthesiology and Pain Medicine, Samsung Medical
Center, 50, Ilwon-Dong, Kangnam-Gu, Seoul, Korea, 135-710</address>
      <phone>82-2-3410-0784</phone>
      <fax />
      <email>hyunjooahn@skku.edu</email>
      <country>Korea, Republic Of</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Hyun Joo Ahn</name>
      <address>Department of Anesthesiology and Pain Medicine, Samsung Medical
Center, 50, Ilwon-Dong, Kangnam-Gu, Seoul, Korea, 135-710</address>
      <phone>82-2-3410-0784</phone>
      <fax />
      <email>hyunjooahn@skku.edu</email>
      <country>Korea, Republic Of</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>